Kees van Grootheest
Impact in
- Toxicology top 0.05%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 5%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Toxicology 36
- Pharmacovigilance and Adverse Drug Reactions 36
-
- Pharmacogenetics and Drug Metabolism 1
- Pharmacology and Obesity Treatment 1
- Co-authors
- Eugène van Puijenbroek (24 shared papers)Florence P. A. M. van Hunsel (13 shared papers)Lolkje de Jong‐van den Berg (4 shared papers)Anneke Passier (5 shared papers)Linda Härmark (9 shared papers)Sten Olsson (2 shared papers)Willem L. Diemont (3 shared papers)Mary Couper (1 shared paper)
- Journals
- Drug Safety (15 papers)Pharmacoepidemiology and Drug Safety (8 papers)European Journal of Clinical Pharmacology (3 papers)British Journal of Clinical Pharmacology (2 papers)Expert Opinion on Drug Safety (2 papers)
- Partner nations
- NetherlandsNew ZealandSwitzerland
In The Last Decade
Kees van Grootheest
42 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 81
- Toxicology 1.3k
- Geriatrics and Gerontology 65
- Pharmacology 76
- Internal Medicine 23
- Family Practice 12
Countries citing papers authored by Kees van Grootheest
This map shows the geographic impact of Kees van Grootheest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kees van Grootheest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kees van Grootheest more than expected).
Fields of papers citing papers by Kees van Grootheest
This network shows the impact of papers produced by Kees van Grootheest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kees van Grootheest. The network helps show where Kees van Grootheest may publish in the future.
Co-authors
The 25 scholars most cited alongside Kees van Grootheest, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 157 | |
| 2 | 2008 | 153 | |
| 3 | 2003 | 144 | |
| 4 | 2011 | 119 | |
| 5 | 2003 | 116 | |
| 6 | 2003 | 91 | |
| 7 | 2009 | 74 | |
| 8 | 2010 | 68 | |
| 9 | 2014 | 67 | |
| 10 | 2004 | 58 | |
| 11 | 2001 | 55 | |
| 12 | 2010 | 48 | |
| 13 | 2012 | 38 | |
| 14 | 2011 | 33 | |
| 15 | 2003 | 32 | |
| 16 | 2009 | 30 | |
| 17 | 2011 | 29 | |
| 18 | 2011 | 29 | |
| 19 | 2010 | 28 | |
| 20 | 2011 | 27 |
About Kees van Grootheest
Kees van Grootheest is a scholar working on Toxicology, Pharmacology, Public Health, Environmental and Occupational Health, Pharmacology and Internal Medicine, having authored 44 papers that have together received 1.7k indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (36 papers), Reproductive Health and Contraception (2 papers), Influenza Virus Research Studies (2 papers), Pharmaceutical Quality and Counterfeiting (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), Venous Thromboembolism Diagnosis and Management (1 paper), Pharmacology and Obesity Treatment (1 paper) and Diabetes Treatment and Management (1 paper). The work is most often cited by research in Toxicology (1.3k citations), Geriatrics and Gerontology (65 citations), Pharmacology (76 citations), Internal Medicine (23 citations) and Family Practice (12 citations). Kees van Grootheest has collaborated with scholars based in Netherlands, New Zealand and Switzerland. Frequent co-authors include Eugène van Puijenbroek, Florence P. A. M. van Hunsel, Lolkje de Jong‐van den Berg, Anneke Passier, Linda Härmark, Sten Olsson, Willem L. Diemont, Mary Couper, Lolkje T.W. de Jong‐van den Berg and Bruno H. Ch. Stricker. Their work appears in journals such as Drug Safety, Pharmacoepidemiology and Drug Safety, European Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology and Expert Opinion on Drug Safety.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.